Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Raging Capital Asks Taro Pharma To Reject Sun Pharma's Acquisition Proposal

Raging Capital Management, LLC , one of the largest unaffiliated shareholders of Taro Pharmaceutical Industries Ltd. (TAROF.PK), announced that it sent a letter to the Board of Directors of Taro demanding that it immediately reject the October 18, 2011 proposal of Sun Pharmaceutical Industries Ltd. to acquire all of the remaining outstanding shares of Taro at a price of $24.50 per share.

Raging Capital stated that it will hold each Taro director personally accountable and liable to the extent the Board accepts any acquisition proposal that undervalues the company.

Click here to receive FREE breaking news email alerts for TARO PHARMACEUTICAL INDUSTRIES LTD and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Following the lackluster performance seen during the previous session, stocks may move to the downside in early trading on Tuesday. The major index futures are currently pointing to a moderately lower open for the markets, with the Dow futures down by 33 points. Germany's investor confidence weakened to a level last seen in late 2012 amid concerns that the rising geopolitical tensions are hurting the European economy, data from the Centre for European Economic Research/ZEW showed Tuesday. The ZEW economic sentiment index fell to 6.9 in September from 8.6 in August. The index has been falling since last January and matched the score seen in December 2012. U.K. inflation slowed marginally as expected in August on falls in prices of motor fuels and food, data from the Office for National Statistics revealed Tuesday. Factory-gate prices declined for the second straight month indicating benign inflationary pressures in the pipeline. Consumer prices rose 1.5 percent year-on-year in August, slower than the 1.6 percent rise in July.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.